Microbiology of bacterial respiratory infections

Pediatric Infectious Disease Journal

Volumn 17, Issue 8 SUPPL., 1998, Pages

  Cappelletty, Diane ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial resistance; Bronchitis; Haemophilus influenzae; Moraxella catarrhalis; Otitis media; Pharyngitis; Sinusitis; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; DISEASE COURSE; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; INFECTION RESISTANCE; MORAXELLA CATARRHALIS; PATHOPHYSIOLOGY; PHARYNGITIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TONSILLITIS;

EID: 0031866712     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199808001-00002     Document Type: Review

References (66)

1. Bartlett G. Management of respiratory tract infections. Baltimore: Williams & Wilkins, 1997.
2. Nord CE. The role of anaerobic bacteria in recurrent episodes of sinusitis and tonsillitis. Clin Infect Dis 1995;20:1512-24.
3. Johnson JA. Pathogenesis of bacterial infections of the respiratory tract. Br J Biomed Sci 1995;52:157-61.
4. Gwaltney JM Jr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992;90:457-62.
5. Wanner A. Clinical aspects of mucociliary transport. Am Rev Respir Dis 1977;116:73-125.
6. Niederman MS. The pathogenesis of airway colonization: lessons learned from the study of bacterial adherence. Eur Respir J 1994;7:1737-40.
7. Niederman MS. Gram-negative colonization of the respiratory tract: pathogenesis and clinical consequences. Semin Respir Infect 1990;5:173-84.
8. Cole P, Wilson R. Host-microbial interrelationships in respiratory infection. Chest 1989;95(Suppl):217S-221S.
9. Wilson R, Pitt T, Taylor G, et al. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest 1987;79:221-9.
10. Denny FW. Effect of a toxin produced by Haemophilus influenzae on ciliated respiratory epithelium. J Infect Dis 1974;129:93-100.
11. Tsang KWT, Rutman A, Tanaka E, et al. Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur Respir J 1994;7:1746-53.
12. Johnson AP, Inzana TJ. Loss of ciliary activity in organ cultures of rat trachea treated with lipo-oligosaccharide from Haemophilus influenzae. J Med Microbiol 1986;22:265-8.
13. Read RC, Wilson R, Rutman A, et al. Interaction of non-typable Haemophilus influenzae with human respiratory mucosa in vitro. J Infect Dis 1991;163:549-58.
14. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83.
15. Apicella MA, Shero M, Dudas KC, et al. Fimbriation of Haemophilus species isolated from the respiratory tract of adults. J Infect Dis 1984;150:40-3.
16. Loek van Alphen L, van den Berghe N, Geelen-van den Broek L. Interaction of Haemophilus influenzae with human erythrocytes and oropharyngeal epithelial cells is mediated by a common fimbrial epitope. Infect Immun 1988;56:1800-6.
17. Bakaletz LO, Tallan BM, Hoepf T, Demaria TF, Birck HG, Lim DJ. Frequency of fimbriation of nontypable Haemophilus influenzae and its ability to adhere to chinchilla and human respiratory epithelium. Infect Immun 1988;56:331-5.
18. Andersson B, Beachey EH, Tomasz A, Tuomanen E, Svanborg-Edén C. A sandwich adhesin on Streptococcus pneumoniae attaching to human oropharyngeal epithelial cells in vitro. Microb Pathog 1988;4:267-78.
19. Watson DA, Musher DM, Verhoef J. Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis 1995;14:479-90.
20. Male CJ. Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoniae. Infect Immun 1979;26:254-61.
21. Wilson R. The pathogenesis and management of bronchial infections: the vicious circle of respiratory decline. Rev Contemp Pharmacother 1992;3:103-12.
22. Pichichero ME. Therapeutic considerations for management of otitis media, sinusitis, and tonsillopharyngitis. Pediatr Asthma Allergy Immunol 1992;6:167-74.
23. Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J 1997;16:449-56.
24. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992; 11(Suppl):S7-11.
25. Wald ER. Microbiology of acute and chronic sinusitis. Immunol Allergy Clin North Am 1994;14:31-45.
26. Mayer KH, Opal SM, Medeiros AA. Mechanisms of antibiotic resistance. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. chap 13. New York: Churchill Livingstone, 1995.
27. Newton DA. Sinusitis in children and adolescents. Prim Care 1996;23:701-17.
28. Siegel JD. Diagnosis and management of acute sinusitis in children. Pediatr Infect Dis J 1987;6:95-9.
29. Gwaltney JM Jr. Acute bronchitis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. chap 47. New York: Churchill Livingstone, 1995.
30. Reynolds HY. Chronic bronchitis and acute infectious exacerbations. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. chap 48. New York: Churchill Livingstone, 1995.
31. Cherry JD. Pharyngitis (pharyngitis, tonsillitis, tonsillopharyngitis, and nasopharyngitis). In: Feigin RD, Cherry JD, eds. Pediatric infectious diseases. 3rd ed. Philadelphia: Saunders, 1992:159-66.
32. Middleton DB. Pharyngitis. Prim Care 1996;23:719-39.
33. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis 1997;25: 574-83.
34. Gerber MA. Antibiotic resistance in group A streptococci. Antimicrob Resist Pediatr 1995;42:539-51.
35. Betriu C, Casado MC, Gomez M, Sanchez A, Palau ML, Picazo JJ. Incidence of erythromycin resistance in group A streptococci (GAS): a 10-year study [Abstract E-115]. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28 to October 1, 1997.
36. Mantero E, Bottaro L, Cruciani M, et al. Erythromycin-resistant Streptococcus pyogenes associated with pharyngitis in Genoa, Italy [Abstract C-72]. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28 to October 1, 1997.
37. Bass JW, Weisse ME, Plymyer MR, Murphy S, Eberly BJ. Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan: comparison with worldwide reports. Arch Pediatr Adolesc Med 1994;148:67-71.
38. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997;337:441-6.
39. Karma P, Palva T, Kouvalainen K, et al. Finnish approach to the treatment of acute otitis media: report of the Finnish Consensus Conference. Ann Otol Rhinol Laryngol Suppl 1987;96:1-19.
40. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 1990;69:307-16.
41. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A. The introduction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985;151:859-68.
42. Rubins JB, Duane PG, Charboneau D, Janoff EN. Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect Immun 1992;60:1740-6.
43. Paton JC, Rowan-Kelly B, Ferrante A. Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 1984;43:1085-7.
44. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
45. Thornsberry C. Activity of selected antimicrobials against penicillin-resistant S. pneumoniae isolates. Infect Med 1997; 14(Suppl A):13-9.
46. Jacobs MR. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J 1996;15:940-3.
47. Spika JS, Facklam RR, Plikaytis BD, et al. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163:1273-8.
48. Mason EO Jr, Kaplan SL, Lamberth LB, Tillman J. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother 1992;36:1703-7.
49. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40: 1208-13.
50. Thornsberry C, Brown SD, Yee YC, Bouchillon SK, Marler JK, Rich T. Increasing penicillin resistance in Streptococcus pneumoniae in the US: effect on susceptibility to oral cephalosporins. Infect Med 1993;10(Suppl D):15-24.
51. Pikis A, Akram S, Donkersloot JA, Campos JM, Rodriguez WJ. Penicillin-resistant pneumococci from pediatric patients in the Washington, DC, area. Arch Pediatr Adolesc Med 1995;149:30-5.
52. Rodriguez WJ, Schwartz RH, Akram S, Khan WN. Streptococcus pneumoniae resistant to penicillin: incidence and potential therapeutic options. Laryngoscope 1995;105:300-4.
53. Mason EO Jr, Lamberth LB, Kershaw NL, Prosser BT. S. pneumoniae antibiotic susceptibility in the United States: 1996-97 [Abstract E-48]. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28 to October 1, 1997.
54. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. M7-A4. Villanova, PA: National Committee for Clinical Laboratory Standards, 1995.
55. Urwin G, Krohn JA, Deaver-Robinson K, et al. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae sero-type b vaccine era. Clin Infect Dis 1996;22:1069-76.
56. Thornsberry C, Burton P, Vanderhoof B, Ogilvie P. Regional differences in beta-lactamase and ampicillin and cefprozil resistance in Haemophilus influenzae in the United States. Adv Ther 1996;13:301-11.
57. Thornsberry C. Antimicrobial resistance in Haemophilus influenzae: a global perspective. Clin Ther 1988;11(Suppl A):20-31.
58. Needham CA. Haemophilus influenzae: antibiotic susceptibility. Clin Microbiol Rev 1988;1:218-27.
59. Fekete T. Bacterial genetics, antibiotic usage, and public policy: the crucial interplay in emerging resistance. Perspect Biol Med 1995;38:363-82.
60. Sanders CC, Sanders WE Jr. Beta-lactam resistance in Gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992;15:824-39.
61. Young H-K, Nandivada LS, Amyes SGB. Antibiotic resistance in the tropics: 1. The genetics of bacterial ampicillin resistance in tropical areas. Trans R Soc Trop Med Hyg 1989;83:38-41.
62. Medeiros AA. Plasmid-determined beta-lactamases. In: Bryan LE, ed. Microbial resistance to drugs. Berlin: Springer-Verlag, 1989:101-27.
63. Doern GV, Brueggemann AB, Pierce G, Holley HP Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997;41: 292-7.
64. Steele RW. Cefprozil: an answer to emerging antimicrobial resistance. Infect Med 1997;14(Suppl A):9-11.
65. Berman S. Otitis media in children. N Engl J Med 1995;332: 1560-5.
66. Doern GV, Brueggemann AB, Pierce G, Hogan T, Holley HP Jr, Rauch A. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:2884-6.